UK's rapid Covid test not yet approved by regulators


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ uks-rapid-covid-test-approved-regulators
Exclusive: no data on accuracy of this and other test bought by government has been published

One of two hours and a half-fast coronavirus tests purchased by the UK government and reported on Monday presently can't seem to be endorsed by controllers, while no information on the precision of either has been distributed, the Guardian has learned.

The test, from Oxford Nanopore, a youthful biotech organization spun off from Oxford University, has not yet increased a CE mark. Before Covid-19, Oxford Nanopore had been included distinctly in research, not tests for patients.

Around 80 other sub-atomic tests had a CE mark as ahead of schedule as of April. DnaNudge was allowed a crisis exception by the Medicines and Healthcare Products Regulatory Agency to be utilized without the CE mark.

Oxford Nanopore and DnaNudge were first name-checked by the wellbeing secretary, Matt Hancock, in a Downing Street question and answer session on 1 May, the day he reported his objective for arriving at 100,000 tests for each day in England had been met.

Hancock plentifully expressed gratitude toward British endeavors to upscale and redesign testing. He referenced the two organizations again from a similar platform on 21 May.

Dissimilar to Oxford Nanopore, DnaNudge - the brainchild of a prominent teacher at Imperial College London - is customarily buyer confronting, with a lead store in Covent Garden, London. DnaNudge sells wristbands in an assortment of hues containing your DNA in a container, broke down from a coincidental cheek swab. Connected to a cell phone application, the wristband will encourage on whether to purchase food items, blazing red or green when you examine the standardized tag.

As ahead of schedule as 22 April, Hancock's area of expertise marked an underlying agreement with DnaNudge for £3.3m, trailed by one for £161m on 1 July.

Tags : #UK #COVID-19 #Regulators

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026